Pulse Biosciences, Inc. (PLSE) Announces Results from Its First Study Evaluating Clinical Target at Major Scientific Meeting
Tweet Send to a Friend
Pulse Biosciences, Inc. (Nasdaq: PLSE) announced clinical efficacy results of its first multi-center study of Nano-Pulse Stimulation (NPS) technology for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
